Genelux CMO files Form 3 with no share holdings

Genelux Corp's Chief Medical Officer, Jason Litten, filed an initial ownership report on Form 3.

Rhea-AI Filing Summary

Genelux Corp's Chief Medical Officer, Jason Litten, filed an initial ownership report on Form 3. The filing identifies him as an officer and confirms that, as of the event date of 01/02/2026, he reports no securities as beneficially owned. The document also includes a power of attorney (Exhibit 24), with the form signed by attorney-in-fact Eric Groen on 01/07/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Genelux Corp (GNLX) Form 3 filing show for Jason Litten?

The Form 3 for Genelux Corp shows that Chief Medical Officer Jason Litten reports no securities beneficially owned as of the event date.

What is the event date on the Genelux (GNLX) Form 3 for Jason Litten?

The event date requiring the Form 3 statement for Jason Litten at Genelux Corp is listed as 01/02/2026.

What is Jason Litten’s role at Genelux Corp (GNLX) in this Form 3?

In the Form 3, Jason Litten is identified as an officer of Genelux Corp, with the title Chief Medical Officer.

Does the Genelux (GNLX) Form 3 report any insider transactions or derivative securities for Jason Litten?

No. The Form 3 includes no transactions in Table I or Table II, and the remarks state that no securities are beneficially owned.

Who signed the Genelux Corp (GNLX) Form 3 for Jason Litten?

The Form 3 is signed by /s/ Eric Groen, Attorney-in-Fact on 01/07/2026, referencing Exhibit 24 – power of attorney.

Is the Form 3 for Genelux (GNLX) filed by one or multiple reporting persons?

The Form 3 is indicated as Form filed by One Reporting Person, referring to Jason Litten.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 05:30 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Litten Jason

(Last) (First) (Middle)

C/O GENELUX CORPORATION

2625 TOWNSGATE ROAD, SUITE 230

(Street)

WESTLAKE VILLAGE CA 91361

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/02/2026

3. Issuer Name and Ticker or Trading Symbol
GENELUX Corp [ GNLX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - power of attorney

No securities are beneficially owned.

	/s/ Eric Groen, Attorney-in-Fact	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.